Advertisement
Screener

ILLUMINA, INC. (ILMN) Research and Development in Process

2.8 / 5 stars · 68/120 Roast Me

ILLUMINA, INC. Research and Development in Process

ILLUMINA, INC. (ILMN) reported Research and Development in Process of $5.42 million for the 12-month period ending 2012-01-01, per its 10-K filed 2012-02-24.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentInProcess · last filed 2012-10-29

  • ILLUMINA, INC. research and development in process for the quarter ending 2012-01-01 was $0.00.
  • ILLUMINA, INC. research and development in process for the quarter ending 2011-10-02 was $0.00.
  • ILLUMINA, INC. research and development in process for the quarter ending 2011-07-03 was $5.42M, a 309.43% increase year-over-year.
  • ILLUMINA, INC. research and development in process for the quarter ending 2011-01-02 was $0.00, a 100.00% decline year-over-year.
  • ILLUMINA, INC. research and development in process for fiscal 2012 was $5.42M, a 309.43% increase from fiscal 2011.
  • ILLUMINA, INC. research and development in process for fiscal 2011 was $1.32M, a 88.30% decline from fiscal 2010.
  • ILLUMINA, INC. research and development in process for fiscal 2010 was $11.32M, a 54.08% decline from fiscal 2008.
  • ILLUMINA, INC. research and development in process for fiscal 2008 was $24.66M.
Period endResearch and Development in Process 3 monthResearch and Development in Process 6 monthResearch and Development in Process 9 monthResearch and Development in Process 12 month
2012-01-01$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$0.00
derived: sum of 2 quarters · filed 2012-10-29
$5.42M
derived: sum of 3 quarters · filed 2012-10-29
$5.42M
10-K · filed 2012-02-24
2011-10-02$0.00
10-Q · filed 2012-10-29
$5.42M
derived: sum of 2 quarters · filed 2012-10-29
$5.42M
10-Q · filed 2012-10-29
2011-07-03$5.42M
10-Q · filed 2012-07-30
$5.42M
10-Q · filed 2012-07-30
2011-01-02$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$0.00
derived: sum of 2 quarters · filed 2012-02-24
$1.32M
derived: sum of 3 quarters · filed 2012-02-24
$1.32M
10-K · filed 2012-02-24
2010-10-03$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$1.32M
derived: sum of 2 quarters · filed 2011-08-10
$1.32M
10-Q · filed 2010-11-05
2010-07-04$1.32M
10-Q · filed 2011-08-10
$1.32M
10-Q · filed 2011-08-10
2010-01-03$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$11.32M
derived: sum of 2 quarters · filed 2012-02-24
$11.32M
10-K · filed 2012-02-24
2009-09-27$1.32M
10-Q · filed 2010-11-05
$1.32M
10-Q · filed 2010-11-05
2008-12-28$24.66M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
AGILENT TECHNOLOGIES, INC. (A)United States$48.720B27.14
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53